NIMSB Celebrates its First Anniversary: Establishing the Future of Precision Medicine

formatos_NIMSB_artigos

The NOVA Institute for Medical Systems Biology (NIMSB) proudly celebrates its first anniversary, marking an important milestone in the establishment of a groundbreaking research institute.

As a collaboration between NOVA University Lisbon (NOVA) and the Max Delbrück Center for Molecular Medicine (MDC), NIMSB is supported by the European Union (Teaming for Excellence – Horizon Europe), the Portuguese Government, and the Municipality of Oeiras.

Although still in its early stages, NIMSB is laying the foundation to become a world-leading Centre of Excellence (CoE) in medical systems biology. The institute is preparing to drive innovation in the development of state-of-the-art systems biology approaches, with the long-term goal of advancing early diagnostics, precision therapies, and delivering real Precision Medicine for patients.

Over the past year, NIMSB has focused on setting up the infrastructure necessary to support cutting-edge research. This includes welcoming the first research groups that will pioneer the institute’s scientific work. By bringing together experts from diverse fields and fostering collaboration with national and international stakeholders, NIMSB is positioning itself to become a leader in medical systems biology.

In the near future, NIMSB will work closely with NOVA Institutes, Schools, affiliated hospitals, and key players in the quadruple-helix model (academia, industry, government, and civil society) to develop a robust ecosystem. This will enable the creation of education and training programs designed to prepare the next generation of researchers and healthcare professionals for the challenges of Precision Medicine.

While the journey is just beginning, NIMSB is on the path to becoming a transformative force in medical systems biology and Precision Medicine, both in Portugal and on a global scale.